Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.

Christine FirthFadi ShamounMichael ApolinarioElisabeth S LimNan ZhangMira T Keddis

Published in: PloS one (2023)

DOACs did not have inferior bleeding or mortality outcomes compared to warfarin in RTRs. There was greater use of warfarin compared to DOACs and a high rate of improper DOAC dose reduction.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
cardiovascular events
risk factors
oral anticoagulants
type diabetes
metabolic syndrome
adipose tissue
glycemic control